Home » Topics » BioWorld

BioWorld
RSS

IMMUNOMEDICS TO GET BROAD PATENT

Jan. 9, 1992

GENSIA, SANDOZ TO PURSUE DIABETES DRUGS

Jan. 9, 1992

GENPHARM RAISES $12 MILLION

Jan. 9, 1992

COLLAGEN LAWSUIT DROPPED

Jan. 9, 1992

MOLECULAR BIO IMAGING AGENT ENTERS PHASE I

Jan. 9, 1992

IMRE ARTHRITIS TREATMENT TRIALS APPROVED

Jan. 9, 1992

GLYCOMED RECEIVES PATENT NOTICE

Jan. 9, 1992

NOVA GETS PATENT FOR LEUMEDIN COMPOUNDS

Jan. 9, 1992

SPAIN APPROVES CYTOGEN'S ONCOSCINT

Jan. 9, 1992

MGI CONVERTS PREFERRED STOCK

Jan. 9, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...